Clinical Trials Browser

Phase 1/2 × Withdrawn × pertuzumab × Clear all

NCT02336984 2021-01-11

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Phase 1/2 Withdrawn

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating